BIOXCEL THERAPEUTICS INC's ticker is and the CUSIP is 09075P955. A total of 3 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12 | -95.6% | 5,000 | -87.9% | 0.00% | – |
| Q2 2023 | $275 | -8.9% | 41,400 | +155.6% | 0.00% | – |
| Q1 2023 | $302 | +4933.3% | 16,200 | +5300.0% | 0.00% | – |
| Q4 2022 | $6 | -99.7% | 300 | +50.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -81.8% | 200 | -81.8% | 0.00% | – |
| Q4 2021 | $22,000 | -70.3% | 1,100 | -57.7% | 0.00% | – |
| Q3 2021 | $74,000 | -1.3% | 2,600 | 0.0% | 0.00% | – |
| Q2 2021 | $75,000 | -75.5% | 2,600 | +3562.0% | 0.00% | -100.0% |
| Q1 2021 | $306,000 | – | 71 | -28.3% | 0.00% | – |
| Q4 2020 | $0 | – | 99 | +73.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 57 | +1.8% | 0.00% | – |
| Q2 2020 | $296,000 | -74.6% | 56 | -89.3% | 0.00% | -100.0% |
| Q1 2020 | $1,164,000 | – | 521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 16,300 | $753,000 | 0.00% |
| SIMPLEX TRADING, LLC | 99 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |